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Abstract The mutation S170A in the proposed nucleotide
binding site of the transcriptional activator protein NTRC
abolishes its ability to catalyse open promoter complex formation
by the cN-RNA polymerase holoenzyme. NTRCS170A has
significant ATPase activity, which, in contrast to the wild-type
protein, is unaffected by phosphorylation or binding to enhancer
sites on DNA. The mutant protein appears to oligomerise
normally on DNA in response to phosphorylation but the
ATPase activity is apparently not responsive to changes in
oligomerisation state. The defect in transcriptional activation is
discussed in relation to mutations in other cN-dependent
activators.
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1. Introduction
The nitrogen regulatory protein NTRC is a member of the
family of response regulators whose activity is controlled by
phosphorylation in response to environmental signals. NTRC
is an enhancer binding protein which activates transcription at
promoters recognised by RNA polymerase and the alternative
sigma factor, cN [1]. The activity of NTRC is regulated
through phosphorylation of an aspartate residue (D54) in its
N-terminal domain by the histidine protein kinase NTRB [2^
4]. The phosphorylated form of NTRC activates transcription
by catalysing the isomerisation of closed promoter complexes
between cN-RNA polymerase and promoter DNA to open
complexes in a reaction which requires ATP hydrolysis [5^
7]. NTRC, in common with other cN-dependent activator
proteins, has a highly conserved central domain containing
a glycine rich motif predicted to form the phosphate binding
loop of the nucleotide binding site [8,9]. This domain is re-
quired for the positive control function of NTRC and is pre-
dicted to interact with cN-RNA polymerase during transcrip-
tional activation [10].
The NTRC protein has been shown to have an ATPase
activity which is phosphorylation dependent and strongly
stimulated by site-speci¢c DNA binding [7,11]. Phosphoryla-
tion causes an increase in the cooperative binding of dimeric
NTRC molecules to adjacent binding sites on enhancer DNA
to form a tetramer or higher order oligomer. The oligomer-
isation of NTRC stimulates the ATPase activity of the protein
which is necessary for the formation of open promoter com-
plexes. [12,13]. Mutant forms of cN-dependent activator pro-
teins with amino acid substitutions in the central domain have
been described which have altered ATPase activity and fail to
activate transcription [14^16]. The defect in transcriptional
activation may be due to lack of ATPase activity, failure to
oligomerise, inability to interact with cN-RNA polymerase at
the promoter or failure to couple ATP hydrolysis to open
complex formation. We have shown previously that a mutant
NTRC protein with a single amino acid substitution, S170A,
in the phosphate binding loop of the ATP binding motif can-
not catalyse open complex formation to activate transcription
but is apparently capable of interacting with cN-RNA polym-
erase at the nifL promoter [9]. We have now characterised the
ATPase activity of this protein and found that it possesses
the unique ability to hydrolyse ATP constitutively. The
ATPase activity of the mutant protein is unusual in that it
is not responsive to the oligomerisation state. The defect in
transcriptional activation in this protein is therefore likely to
be due to failure to couple ATP hydrolysis to open complex
formation.
2. Materials and methods
2.1. Plasmid DNA and oligonucleotides
Plasmid pMS160A containing the nifLA promoter regulatory re-
gion has been described previously [17]. Oligonucleotides were syn-
thesised on an Applied Biosystems 381A synthesiser and puri¢ed by
polyacrylamide electrophoresis [18]. Three oligonucleotides were used
to construct synthetic NTRC binding sites: A: 5P-TTGCTTTGCAC-
TACCGCGGCCCATCCCTGCCCCAAAACGATCGCTTCAGCC-
3P ; B: 5P-TTGCTTTGTACTACCGCGGCCCATCCCTGCCCCAA-
AACGATCGCTTCAGCC-3P ; C: 5P-CATCCCTGCCCCAAAACG-
ATCGCTTCAGCC-3P.
The primer 3P-GGGTTTTGCTAGCGAAGTCGG-5P was an-
nealed to make the oligonucleotides double-stranded. The Klenow
fragment of DNA polymerase I was used to ¢ll in the 5P extension
in the presence of all four deoxynucleotide triphosphates. DNA tem-
plates for the gel mobility shift assays were based on the consensus
enhancer binding site [12]. Two primers, 5P-GGAATTCGTTGC-
ACTAAAATGGTGCATAATGTTAACATTAATG-3P and 5P-CCG-
GATCCGTTGCACCATTTTAGTGCATTAATGTTAACATTA -3P,
with complementary 3P ends containing the strong enhancer binding
sites (underlined), were annealed and extended to produce a double
stranded oligonucleotide. This was cloned as an EcoRI-BamHI frag-
ment into pUC18 and the resultant plasmid used as a template to
produce a 153bp PCR fragment using pUC18 primers 5P-AT-
TAAGTTGGGTAACGCCAG-3P and 5P-AATTTCACACAGGAA-
ACAGC-3P complementary to the sequence on either side of the in-
sert. The PCR fragment containing the enhancer binding sites was
then itself used as a template for a further round of PCR with the
same pUC18 primers to internally label the PCR product with
[K-33P]ATP.
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2.2. Proteins
Wild-type NTRC from Klebsiella pneumoniae was puri¢ed from
extracts of Escherichia coli ET8894 carrying the plasmid pTH1 as
described previously [19]. NTRCS170A and NTRCS170L were puri¢ed
from overproducing strains as described previously [17] except that
after MonoQ chromatography further puri¢cation was achieved by
gel ¢ltration on Superose 12 (Pharmacia). NTRB was puri¢ed as
described previously [17].
2.3. ATPase assay
ATPase assays were performed in acetate bu¡er containing 50 mM
Tris-acetate pH 7.9, 100 mM potassium acetate, 8 mM magnesium
acetate, 27 mM ammonium acetate, 1 mM DTT, 3.5% PEG 6000.
Final total volume was 10 Wl. Phosphorylation was achieved by pre-
incubation of the proteins at 37‡C for 12 min with carbamoyl phos-
phate. ATPase reactions were initiated by addition of unlabelled ATP
mixed with [Q-32P]ATP (3000 Ci mmol, Amersham). Incubations were
at 25‡C for 1 h. The ¢nal ATP concentration in the assay was 3 mM.
One tenth volume of 5% SDS, 20 mM EDTA was used to stop the
reaction. The amount of 32Pi released was determined by thin-layer
chromatography in 0.75 M potassium dihydrogen phosphate bu¡er
pH 3.5. 1 Wl samples were spotted onto polyethyleneimine cellulose
plates (Macherey-Nagel) and dried. The amount of 32Pi released was
quanti¢ed using a Fujix BAS1000 phosphoimager. The values ob-
tained were expressed as pmol ATP hydrolysed per ml of reaction
per hour unless stated otherwise. The concentration of NTRC was
500 nM if not otherwise stated, carbamoyl phosphate was used at a
¢nal concentration of 15 mM. Plasmid DNA was used at a concen-
tration of 20 mM and oligonucleotides at a concentration of half the
molar concentration of NTRC present in the assay.
2.4. Gel shift mobility assays
Reactions mixtures for binding assays contained 10 mM Tris ace-
tate pH 8, 100 mM potassium acetate, 8 mM magnesium acetate, 27
mM ammonium acetate, 0.5 mM DTT, 2 mM ATP, 1.5 Wg/ml poly-
d(I-C) and 6 pM internally labelled probe. NTRC or NTRCS170A was
serially diluted in storage bu¡er (10 mM Tris-HCl pH 8.0, 50 mM
KCl, 5% glycerol, 1 mM DTT, 1 mM EDTA, 0.2 mg/ml acetylated
bovine serum albumin) to give ¢nal concentrations in the assay be-
tween 0.012 and 50 nM in a ¢nal volume of 20 Wl. Where present
NTRB was used at 20 nM. Reaction mixtures were incubated at 37‡C
for 20 min, then 2 Wl of loading bu¡er was added and the mixture
loaded onto a 5% acrylamide 0.06% bisacrylamide gel running at 16
V/cm. The gel which had been pre-run for 20 min prior to loading was
run in 360 mM glycine, 50 mM Tris-HCl bu¡er pH 8.6 for 1 h at 4‡C.
Gels were dried and the complexes were visualised and quantitated
with a Fujix BAS1000 phosphoimager. Co-operativity factors were
measured as described [20,12].
3. Results
3.1. The NTRCS170A mutant protein has constitutive ATPase
activity
Although NTRCS170A is defective in open complex forma-
tion and cannot activate transcription, the puri¢ed protein
exhibits constitutive ATPase activity. Fig. 1 shows a compar-
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Fig. 1. Comparison of the ATPase activities of NTRCS170A,
NTRCS170L and wild-type NTRC. Reactions containing 500 nM
wild-type or mutant NTRC proteins were incubated as described in
Section 2 for 1 h at 25‡C in the presence or absence of pMS160A
supercoiled plasmid DNA (¢nal concentration 20 nM) and/or carba-
moyl phosphate (¢nal concentration 15 mM). Hydrolysis was initi-
ated by addition of 3 mM [Q-32P]ATP. 1 Wl aliquots were removed
for analysis of phosphate release by TLC as described in Section 2.
Open bars indicate the absence of DNA and carbamoyl phosphate;
cross-hatched bars indicate the presence of carbamoyl phosphate,
grey-¢lled bars indicate reactions contained DNA and ¢lled bars the
presence of DNA plus carbamoyl phosphate. The inset shows a
time course of ATP hydrolysis by the NTRCS170A mutant protein in
the absence of DNA and carbamoyl phosphate.
Fig. 2. Dependence of ATPase activity on NTRC protein concentra-
tion. Reactions containing the indicated amounts of wild-type
NTRC (A) or NTRCS170A (B) were incubated as described in Sec-
tion 2 for 1 h at 25‡C in the presence of double-stranded oligo nu-
cleotides (500 nM ¢nal concentration); A (square symbols), B (tri-
angles), or C (diamonds) or in the absence of DNA (circles, dashed
line). Filled symbols indicate that carbamoyl phosphate was present
where indicated at a ¢nal concentration 15 mM. 1 Wl aliquots were
removed for analysis of phosphate release by TLC as described in
Section 2.
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ison of the ATPase activities of wild-type NTRC, NTRCS170A
and another mutant protein with a serine to leucine substitu-
tion in the same residue, NTRCS170L. As we have shown pre-
viously [11], the ATPase activity of wild-type NTRC was
stimulated by phosphorylation and DNA binding, in contrast
to NTRCS170A which hydrolysed ATP in the absence of both
e¡ectors. Neither phosphorylation nor the presence of plas-
mid DNA carrying NTRC binding sites causes an increase in
the level of the constitutive ATPase activity of NTRCS170A.
The time course of ATP hydrolysis by NTRCS170A was linear
for up to 1 h under the conditions of the assay and the rate
was approximately 43% of that observed with the phosphoryl-
ated wild-type protein in the presence of plasmid DNA. The
NTRCS170L protein showed only a low background level of
ATPase activity as observed with the non-phosphorylated
wild-type protein under all conditions tested. S170L, like
NTRCS170A, is unable to activate transcription but both pro-
teins are phosphorylated normally by NTRB [9] (and data not
shown). Both NTRCS170A and NTRCS170L were extensively
puri¢ed using the same procedure developed for the wild-
type protein and showed identical chromatographic behav-
iour.
3.2. The ATPase activity of NTRCS170A is not in£uenced by the
presence of the enhancer
Wild-type NTRC is only active as an ATPase when it is
able to oligomerise [12,13]. At low protein concentrations
ATPase activity is observed when phosphorylation stimulates
cooperative binding of dimeric NTRC molecules to adjacent
sites on DNA. At higher protein concentrations higher order
oligomers of phosphorylated NTRC can form in the absence
of DNA and ATPase activity is observed in the absence of
DNA binding. This is demonstrated in Fig. 2 which shows the
e¡ect of site-speci¢c DNA binding on the ATPase activity of
wild-type NTRC and NTRCS170A. DNA binding sites were
provided on short double-stranded oligonucleotides contain-
ing either the natural enhancer from the nifL promoter region,
which contains two NTRC binding sites (sites 1 and 2, oligo
A) permitting co-operative interaction between bound dimers,
or alternatively a single site which is expected to bind only a
dimer (site 2 only, oligo C). A third oligonucleotide (oligo B)
contained the natural enhancer but with a C to T substitution
in binding site 1, which has been shown previously to cause a
reduction in ATPase activity compared to that observed with
two wild-type sites [11]. The non-phosphorylated wild-type
protein was unable to hydrolyse ATP under any of the con-
ditions tested. The level of ATPase activity observed with the
phosphorylated protein alone was similar to that in the pres-
ence of a single NTRC binding site indicating that NTRC is
unable to oligomerise on this DNA template (Fig. 2A). The
ATPase activity of wild-type NTRC was strongly stimulated
in the presence of the oligonucleotide containing both wild-
type NTRC binding sites and the stimulation was reduced in
the presence of the mutant site, in accord with our previous
results [11]. In contrast, the ATPase activity of NTRCS170A, in
either its non-phosphorylated or phosphorylated form (data
not shown), was not in£uenced by any of the oligonucleotides
(Fig. 2B). However, the response to protein concentration was
slightly sigmoidal, suggestive of weak co-operative interaction
in solution. Thus it would appear that oligomerisation of the
NTRCS170A protein is not required for ATPase activity and
that unlike the wild-type protein it can probably hydrolyse
ATP as a dimer. The possibility that the native NTRCS170A
protein already exists in an oligomeric state can be eliminated
by two lines of evidence. Firstly, the molecular mass of puri-
¢ed NTRCS170A was identical to the wild-type protein as
judged by gel ¢ltration chromatography (data not shown)
and secondly, the association state of NTRCS170A as measured
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Fig. 3. Comparison of the binding of wild-type NTRC and NTRCS170A to the strong glnA enhancer. Binding was measured using gel mobility
shift assays with the 153 bp internally labelled PCR product using the pUC18 primers. The concentration of NTRC is shown above each lane.
NtrB (20 nM) was present in reactions analysed in panels C and D. Co-operativity factors were determined by quantitating the relative propor-
tions of each shifted species using a Fujix BAS1000 phosphoimager.
D. Widdick et al./FEBS Letters 437 (1998) 70^7472
by sedimentation equilibrium centrifugation was similar to
that of the unphosphorylated wild-type protein, both in the
presence and absence of ATP (B. Davidson and T. Wilson,
personal communication).
3.3. The NTRCS170A mutant protein appears to assemble
normally at the enhancer
The failure to observe DNA-dependent stimulation of the
ATPase activity of NTRCS170A could re£ect either a defect in
the ability of the mutant protein to interact with speci¢c DNA
binding sites or failure to bind co-operatively to more than
one site to form a higher order oligomer. Previous DNAse I
footprinting studies indicated that the former possibility is
unlikely [9] but the cooperative binding of NTRCS170A to
multiple sites on DNA was not studied in detail. The ability
of NTRCS170A to bind cooperatively to DNA compared to
wild-type NTRC was assessed by a gel mobility shift assay
using PCR generated probes containing the consensus en-
hancer binding sites [12]. Binding of low concentrations
(s 50 nM) of non-phosphorylated NTRC to this enhancer
gives rise to two shifted species corresponding to a single
dimer and a tetramer respectively [12] ; both species were ob-
served upon binding of either wild-type or NTRCS170A at
similar protein concentrations (Fig. 3, compare panels A
and B). The fractional maximum of the intermediate dimer
bound species was also similar in both cases, corresponding to
a co-operativity factor of V5 [12,20]. Quantitation of the
total amount of probe shifted by all the retarded species
gave similar binding curves for both non-phosphorylated pro-
teins with half maximal binding to the DNA occurring at a
protein concentration of approximately 30 nM for both
NTRCS170A and NTRC (Fig. 4). When phosphorylated,
both proteins showed an increase in cooperative binding to
the enhancer yielding more of the shifted species correspond-
ing to the bound tetramer and the appearance of a further
higher order species of unknown association state at protein
concentrations of 50 nM and above (Fig. 3, compare panels C
and D). Under these conditions the wild-type protein shifted
the probe at lower protein concentrations than NTRCS170A
(Fig. 4), but quantitation of the free probe, intermediate
and fully shifted species indicated a similar co-operativity fac-
tor of V45. Since the co-operativity calculations are inde-
pendent of the concentration of active protein the di¡erences
in the binding isotherms possibly represent minor di¡erences
in the level or response to phosphorylation. NTRCS170A there-
fore appears to assemble normally on DNA and phosphoryl-
ation of the mutant protein increases the cooperativity of
DNA binding in a similar manner to the wild-type protein.
4. Discussion
The pathway which leads to the assembly of an active form
of NTRC protein, capable of hydrolysing ATP is complex.
Oligomerisation appears to be an essential event in the process
promoted by (i) phosphorylation of the N-terminal domain
which stimulates co-operative binding to multiple sites in the
enhancer [11^13] and (ii) binding of ATP to the central do-
main which stimulates oligomerisation possibly by promoting
a conformational change in the protein [15,19,21]. The dimer
form of wild-type NtrC is apparently inactive as an ATPase
and is not competent to activate transcription. NTRCS170A
appears to oligomerise under similar conditions to the wild-
type protein, since phosphorylation stimulates co-operative
binding to DNA and the non-phosphorylated form of the
protein is not highly associated even in the presence of
ATP. However the ATPase activity of the mutant protein
appears to be completely uncoupled from its oligomerisation
state since the unphosphorylated dimeric protein has catalytic
activity, which does not apparently increase when the protein
undergoes oligomerisation. The ATPase activity of the mutant
protein is also uncoupled from transcriptional activation.
Thus it would appear that the hydrolysis of ATP by the mu-
tant protein is not allosterically regulated and the energy of
hydrolysis cannot be utilised to drive formation of the open
promoter complex by the cN holoenzyme.
The central activation domains of cN-dependent activators
are well conserved and have been subdivided into seven re-
gions of strong homology designated C1^C7 [10,22]. The re-
gion C1 is the predicted nucleotide binding site containing the
glycine rich motif (GXXXXGK) found in many nucleotide
binding proteins [23]. The central domain of NTRC shows
homology with this motif between residues 168 and 175 and
secondary structure predictions based on the EF-Tu fold as a
model indicate that this region connects a L-sheet with an K-
helix [9,23]. The NTRCS170A mutation is not predicted to dis-
rupt the structure of the phosphate binding loop [9]. Analo-
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Fig. 4. Quantitation of the cooperative binding by wild-type NTRC
and NTRCS170A to the strong glnA enhancer. Data are taken from
Fig. 3 and represent the total amount of shifted species as a per-
centage of the total radioactivity present in each lane. In panel A
the binding of non-phosphorylated wild-type (closed squares) and
NTRCS170A proteins (closed triangles) are compared. Data in panel
B are taken from Fig. 3C,D and compare wild-type (open squares)
and NTRCS170A proteins (open triangles) in reactions containing
NTRB.
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gous mutations (S242A and S242G) in the equivalent residue
in the K. pneumoniae NIFA protein are also defective in tran-
scriptional activation but the phenotype is less severe than
found with NTRCS170A suggesting that these mutants may
have signi¢cant ATPase activity [24]. However, the equivalent
mutation, T175A, in the constitutively active truncated form
of the Rhizobium meliloti DctD protein (DctDv1ÿ142;T175A)
disrupts both transcriptional activation and ATP hydrolysis
[25]. In the case of K. pneumoniae NTRC the hydroxyl side
chain may be critical for regulation of ATPase activity, per-
haps because it is involved in allosteric modulation via inter-
action with another region of the protein. Thus although the
NTRCS170A protein can bind and hydrolyse ATP, the confor-
mation of the protein may be altered in such a way that the
dependence on oligomerisation state for ATPase activity is
lost, as well as the ability to couple ATP hydrolysis to open
complex formation. Although it would appear that
NTRCS170A is able to interact with the cN holoenzyme, the
latter defect could nevertheless be a consequence of a non-
productive interaction. Substitution of the serine residue with
leucine at this position (the S170L mutation) may alter the
conformation of the loop so that either ATP binding or hy-
drolysis is impaired.
Derivatives of cN-dependent activators have been reported
which have constitutive transcriptional activity due either to
deletion of their N-terminal domains or to single amino acid
substitutions in the N-terminal or central domains [26^32].
These proteins exhibit constitutive ATPase activity as a con-
sequence of their ability to bypass the control of catalytic
activity exerted by the amino-terminal domain. However,
the relationship between catalytic activity and oligomerisation
state has not yet been clearly de¢ned in many of these cases.
A number of other mutations in the central domains of both
NTRC and other cN-dependent activators have been de-
scribed which produce transcriptionally inactive proteins
where the ATPase activities are altered or abolished by the
mutation [7,14^16]. Where signi¢cant ATPase activity is ob-
served with these mutants it appears to be coupled in the
normal way to the assembly of oligomers on the appropriate
enhancer binding site. In none of these cases have the mutant
proteins been shown to hydrolyse ATP uncoupled to the in-
teraction with e¡ectors, which appears to be a unique prop-
erty of the NTRCS170A mutation. However, some mutations in
the conserved C3 region of the central domain, which is re-
quired for productive interaction with cN holoenzyme, have
relatively high levels of ATPase activity suggesting that, like
NTRCS170A, they may fail to couple ATP hydrolysis to the
formation of open promoter complexes [14,16]. Although a
quantitative measure of the stoichiometry of ATP hydrolysis
to open complex formation has not been reported it seems
likely that NTRCS170A possesses enough ATPase activity to
support transcription if there was no other defect. NTRCS170A
possesses signi¢cantly more ATPase activity than the non-
phosphorylated form of the NTRCS160F mutant protein which
is fully competent to activate transcription [7,11,26]. Therefore
multimerisation and ATP hydrolysis by NTRC are not the
only prerequisites for activating formation of the open com-
plex by cN holoenzyme, conformational changes in the acti-
vator during the catalytic cycle may be required to engage the
polymerase and thus couple the energy of ATP hydrolysis to
DNA strand separation.
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